Table 6
Comparison between the areas surrounding Trillo for risk of more and less radioinducible malignant tumours, and for each of the three study periods
| T10–T30 | T10–T20 | T10–ZCI | T10–Rest of Trillo | |
|---|---|---|---|---|
| Period 1 (1989–93) | ||||
| More radioinducible tumours | ||||
| Cases | 28–49 | 28–21 | 28–49 | 28–119 |
| Controls | 23–60 | 23–19 | 23–39 | 23–118 |
| OR | 1.49 | 1.10 | 0.96 | 1.21 |
| 95% CI | 0.72 to 3.07 | 0.44 to 2.75 | 0.46 to 2.06 | 0.66 to 2.21 |
| p value | 0.31 | 0.98 | 0.99 | 0.65 |
| Less radioinducible tumours | ||||
| Cases | 8–13 | 8–8 | 8–22 | 8–43 |
| Controls | 23–56 | 23–19 | 23–38 | 23–113 |
| OR | 1.50 | 0.83 | 0.60 | 0.91 |
| 95% CI | 0.53 to 4.24 | 0.26 to 2.62 | 0.24 to 1.51 | 0.38 to 2.17 |
| p value | 0.60 | 0.98 | 0.42 | 0.99 |
| Period 2 (1994–96) | ||||
| More radioinducible tumours | ||||
| Cases | 22–37 | 22–18 | 22–26 | 22–81 |
| Controls | 23–53 | 23–20 | 23–34 | 23–107 |
| OR | 1.37 | 1.06 | 1.25 | 1.26 |
| 95% CI | 0.67 to 2.82 | 0.45 to 2.52 | 0.58 to 2.72 | 0.66 to 2.43 |
| p value | 0.50 | 0.99 | 0.71 | 0.29 |
| Less radioinducible tumours | ||||
| Cases | 4–13 | 4–3 | 4–2 | 4–18 |
| Controls | 33–75 | 33–31 | 33–51 | 33–157 |
| OR | 0.70 | 1.25 | 3.09 | 1.06 |
| 95% CI | 0.23 to 2.14 | 0.26 to 5.97 | 0.57 to 16.64 | 0.56 to 5.74 |
| p value | 0.76 | 0.99 | 0.79 | 0.99 |
| Period 3 (1997–99) | ||||
| More radioinducible tumours | ||||
| Cases | 25–23 | 25–18 | 25–24 | 25–65 |
| Controls | 8–34 | 8–21 | 8–27 | 8–82 |
| OR | 4.61 | 3.65 | 3.52 | 3.94 |
| 95% CI | 1.96 to 10.90 | 1.42 to 9.38 | 1.96 to 8.55 | 1.85 to 8.38 |
| p value | 0.003 | 0.021 | 0.017 | 0.002 |
| Less radioinducible tumours | ||||
| Cases | 1–6 | 1–2 | 1–9 | 1–17 |
| Controls | 10–42 | 10–24 | 10–34 | 10–100 |
| OR | 0.70 | 1.20 | .38 | 0.59 |
| 95% CI | 0.09 to 5.31 | 0.09 to 15.88 | 0.07 to 2.08 | 0.10 to 3.48 |
| p value | 0.99 | 0.99 | 0.64 | 0.97 |
